CANNRA URGES FEDERAL ACTION TO ADDRESS HEMP-DERIVED CANNABINOID PRODUCT REGULATION
CANNRA urges federal action to provide a regulatory framework for hemp-derived cannabinoid products. These products currently lack federal manufacturing, testing, and labeling requirements, and they pose consumer safety and public health risks. In the absence of federal regulation, state government agencies have borne the brunt of the efforts to effectively regulate cannabinoid hemp products.
This letter outlines the three major loopholes being used to justify the sale of intoxicating hemp-derived products: the “0.3% loophole,” the “THCA loophole,” and the “derivatives loophole.” The letter discusses several key considerations raised by state cannabis and hemp regulators as the Farm Bill language is revised and cannabinoid hemp product regulation is debated. As regulatory discussions on this topic continue, state cannabis and hemp regulators are vital to have at the table as a group of government officials with direct regulatory experience related to cannabinoid products.
